NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that it has priced $800 million of senior notes.

The Waltham, Massachusetts-based research tools and lab products giant has priced an offering of $450 million aggregate principal amount of 2.15 percent senior notes due 2018 and $350 million aggregate principal amount of 3.65 percent senior notes due 2025. The issuance of the notes is expected to close on or around Dec. 9, and the firm said the notes will pay interest semi-annually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.